AARD
Alanine- and arginine-rich domain-containing protein
Also known as: AARD_HUMAN, C8orf85, LOC441376
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q4LEZ3
- Gene
- AARD
- Ensembl
- ENSG00000205002
- Chromosome
- 8
- Canonical length
- 155 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Lipid droplets
OverviewNCBI Gene
Predicted to act upstream of or within response to testosterone. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
155 residues, UniProt reviewed canonical sequence.
>Q4LEZ3|AARD
1 MGPGDFRRCR ERISQGLQGL PGRAELWFPP RPACDFFGDG RSTDIQEEAL AASPLLEDLR
61 RRLTRAFQWA VQRAISRRVQ EAAAAAAARE EQSWTGVEAT LARLRAELVE MHFQNHQLAR
121 TLLDLNMKVQ QLKKEYELEI TSDSQSPKDD AANPELocalizationUniProt · AlphaFold · HPA
Whether an antibody against AARD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- testis: 21 nTPM
- urinary bladder: 7.1 nTPM
- stomach: 6.4 nTPM
- colon: 5.4 nTPM
- breast: 4 nTPM
- lung: 2.4 nTPM
Single-cell type
- late primary spermatocytes: 126 nCPM
- sertoli cells: 78 nCPM
- breast secretory cells: 60 nCPM
- smooth muscle cells: 40 nCPM
- breast myoepithelial cells: 25 nCPM
- late spermatids: 25 nCPM
Immune cell
- basophil: 1.1 nTPM
- neutrophil: 0.7 nTPM
- T-reg: 0.6 nTPM
- NK-cell: 0.3 nTPM
- classical monocyte: 0.2 nTPM
- plasmacytoid DC: 0.2 nTPM
Brain region
- white matter: 3.6 nTPM
- midbrain: 3.2 nTPM
- cerebral cortex: 3 nTPM
- medulla oblongata: 3 nTPM
- pons: 2.9 nTPM
- choroid plexus: 2.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.1
- gnomAD pLI
- 0.33
- gnomAD missense Z
- -0.31
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Protein domainsUniProt · Pfam · InterPro
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AARD as an antibody target. Whether an autoantibody or antibody against AARD could matter depends on whether native AARD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AARD is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AARD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...